Literature DB >> 8224073

Paradoxical sleep deprivatory effect of a single low dose of MPTP which did not produce dopaminergic cell loss.

K Pungor1, A Hajnal, K A Kékesi, G Juhász.   

Abstract

In a previous study, we reported on a selective and long-lasting paradoxical sleep (PS) deprivation in cats following repeated administration of the Parkinson syndrome-inducing neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). While the characteristic motor deficits occurred only from the 2nd to 3rd day of a 5-day long administration of 5 mg/kg per day MPTP i.p., the PS deprivation started immediately after the first injection and lasted altogether for 11-13 days. The motor deficiencies induced by repeated administration of MPTP are mainly due to the selective depletion of dopaminergic neurons in the nigrostriatal system as the histological and biochemical data show. The immediate onset of PS deprivation and the PS recovery, despite the definite cell loss, suggests a mechanism independent of cell destruction. In our present study we investigated the occasional histological and the PS-deprivatory effect of a single low dose of MPTP in cats. A single injection of 2 mg/kg MPTP i.p. resulted in PS deprivation lasting for 2.5-3.5 h. The duration of other sleep stages showed no significant change and PS recovery was without rebound phenomenon, as in the case of repeated administration. Even a higher single dose of MPTP (5 mg/kg) resulted in no visibly detectable nigrostriatal cell loss. We suggest that the changes in monoamine release and/or turnover are involved in the PS deprivatory effect of MPTP.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8224073     DOI: 10.1007/bf00227140

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  16 in total

Review 1.  Paradoxical sleep and its chemical/structural substrates in the brain.

Authors:  B E Jones
Journal:  Neuroscience       Date:  1991       Impact factor: 3.590

Review 2.  MPTP: current concepts and controversies.

Authors:  J W Langston; I Irwin
Journal:  Clin Neuropharmacol       Date:  1986       Impact factor: 1.592

3.  Uptake of MPP(+) by dopamine neurons explains selectivity of parkinsonism-inducing neurotoxin, MPTP.

Authors:  J A Javitch; S H Snyder
Journal:  Eur J Pharmacol       Date:  1984-11-13       Impact factor: 4.432

4.  A novel effect of MPTP: the selective suppression of paradoxical sleep in cats.

Authors:  K Pungor; M Papp; K Kékesi; G Juhász
Journal:  Brain Res       Date:  1990-08-20       Impact factor: 3.252

5.  Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase.

Authors:  K Chiba; A Trevor; N Castagnoli
Journal:  Biochem Biophys Res Commun       Date:  1984-04-30       Impact factor: 3.575

6.  Selective accumulation of MPP+ in the substantia nigra: a key to neurotoxicity?

Authors:  I Irwin; J W Langston
Journal:  Life Sci       Date:  1985-01-21       Impact factor: 5.037

7.  Production of a Parkinson-like syndrome in the cat with N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): behavior, histology, and biochemistry.

Authors:  J S Schneider; A Yuwiler; C H Markham
Journal:  Exp Neurol       Date:  1986-02       Impact factor: 5.330

8.  MPTP neurotoxicity: an overview and characterization of phases of toxicity.

Authors:  J W Langston
Journal:  Life Sci       Date:  1985-01-21       Impact factor: 5.037

9.  Neurochemical and behavioral effects of systemic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the rat.

Authors:  C C Chiueh; S P Markey; R S Burns; J N Johannessen; A Pert; I J Kopin
Journal:  Eur J Pharmacol       Date:  1984-04-20       Impact factor: 4.432

Review 10.  MPTP: an industrial chemical and contaminant of illicit narcotics stimulates a new era in research on Parkinson's disease.

Authors:  I J Kopin
Journal:  Environ Health Perspect       Date:  1987-11       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.